Search Orphan Drug Designations and Approvals
-
Generic Name: | firtecan pegol |
---|---|
Date Designated: | 04/18/2011 |
Orphan Designation: | Treatment of neuroblastoma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Enzon Pharmaceuticals, Inc. 20 Kingsbridge Road Piscataway, New Jersey 08854 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-